FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.



More Latest News

Class III Institutional Pharmacies
October 17, 2018

Beginning on October 19, 2018, the Board of Pharmacy will be issuing permits for this new class of pharmacy. Continue reading


Operating Mobile Pharmacies Under The Emergency Order
October 12, 2018

Please Click Here for More Information Regarding: Operating Mobile Pharmacies Under The Emergency Order Continue reading